Sabra Health Care REIT, Inc.
SBRANASDAQReal EstateREIT - Healthcare Facilities
As of Oct 22, 2026 close
- Market cap
- $4.94B
- P/E (TTM)
- 75.56
- Forward P/E
- 150.42
- Dividend yield
- 6.12%
- 52-week range
- $17.17$22.77
- Volume (live)
- -
- Avg. volume (3M)
- 2.45M
Sabra Health Care REIT (SBRA) Stock Price & Financial Analysis
Sabra Health Care REIT Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $18.88 - $19.66 |
|---|---|
| 52-Week High | $22.77 |
| 52-Week Low | $17.17 |
| Open | $18.97 |
| Volume (last close) | 2.43M |
| Average Volume (3M) | 2.45M |
| Revenue (TTM) | 846.89M |
|---|---|
| Net Income (TTM) | 65.44M |
| Free Cash Flow (TTM) | -181.29M |
| EPS (TTM) | $0.26 |
| Profit Margin | 7.73% |
| Operating Margin | 17.14% |
| Return on Equity (ROE) | 2.38% |
| Debt to Equity | 0.95 |
| Annual Dividend | $1.20 |
|---|---|
| Dividend Yield | 6.12% |
| Payout Ratio | 200.00% |
| Last Dividend Ex-Date | Aug 14, 2026 |
| Market Cap | 4.94B |
|---|---|
| Shares Outstanding | 252.27M |
| P/E Ratio (TTM) | 75.56 |
| Forward P/E | 150.42 |
| Price to Sales (P/S) | 5.84 |
| Price to Book (P/B) | 1.80 |
| EV/EBITDA | 20.09 |
| 50-Day MA | $20.00 |
|---|---|
| 200-Day MA | $19.97 |
| 1-Year Change | +7.63% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Sabra Health Care REIT at a Glance
As of the Oct 22, 2026 close, Sabra Health Care REIT (SBRA) has a market capitalization of $4.94B. The stock trades at 75.6× trailing earnings, 150.4× forward earnings and 5.8× sales. Over the trailing twelve months it earned $65.44M on revenue of $846.89M (a 7.7% profit margin) and burned $181.29M of free cash flow. Revenue grew 19.0% year over year.
As of its latest reported balance sheet, it holds $231.58M in cash and securities against $2.63B of debt, a net debt position of $2.39B.
Sabra Health Care REIT pays a quarterly dividend totaling $1.20 per share a year, a 6.12% yield at the Oct 22, 2026 close.
The share price is up 7.6% over the past year. At $19.60 (the Oct 22, 2026 close) it sits within its 52-week range of $17.16 to $22.77, below its 200-day moving average of $19.97.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $22.00, 12.2% above the Oct 22, 2026 close.
Frequently Asked Questions About Sabra Health Care REIT
What is the current stock price for SBRA?
As of the Oct 22, 2026 close, SBRA stock trades at $19.60. The 52-week range is $17.17–$22.77, with a day range of $18.88–$19.66.
What is the P/E ratio for SBRA?
As of the Oct 22, 2026 close, Sabra Health Care REIT's trailing twelve-month (TTM) P/E ratio is 75.6, meaning investors pay $75.6 for every $1 of annual earnings. The forward P/E is 150.4, reflecting analyst expectations for future earnings. Sabra Health Care REIT operates in the Real Estate sector.
Does SBRA pay dividends?
Yes, Sabra Health Care REIT pays a 6.12% annual dividend yield as of the Oct 22, 2026 close ($1.20 per share a year). The trailing twelve-month payout ratio is 200.0%. The most recent ex-dividend date was August 14, 2026.
What do analysts recommend for SBRA?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for SBRA is Hold. The average 12-month price target is $22.00, a 12.2% upside from the Oct 22, 2026 close of $19.60.
What is the market cap of SBRA?
As of the Oct 22, 2026 close, Sabra Health Care REIT's market capitalization is $4.94B, classifying it as a mid-cap company. Sabra Health Care REIT operates in the Real Estate sector within the REIT - Healthcare Facilities industry.